Pancreatic Cancer Research

ResearcherJiangsu UniversityNo recent work listed

Wei Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7173-9740; OpenAlex author ID A5100344322. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: 1 paper

Papers 3

  1. Erratum: miR-455-3p Functions as a Tumor Suppressor by Restraining Wnt/β-Catenin Signaling via TAZ in Pancreatic Cancer [Corrigendum]. Co-author DOI 10.2147/cmar.s387344↗
  2. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells. Co-author DOI 10.1002/jcb.29308↗
  3. Methyl-CpG-binding domain 3 inhibits stemness of pancreatic cancer cells via Hippo signaling. Co-author DOI 10.1016/j.yexcr.2020.112091↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huizhi Wang · 2 shared papers, 2020 · strength 0.20
  2. Aihua Gong · 2 shared papers, 2020 · strength 0.20
  3. Min Xu · 2 shared papers, 2020 · strength 0.20
  4. Zheng Han · 1 shared paper, 2022 · strength 0.14
  5. Xiaodong Huang · 1 shared paper, 2022 · strength 0.14
  6. Ting Zhan · 1 shared paper, 2022 · strength 0.14
  7. Tian Xia · 1 shared paper, 2022 · strength 0.14
  8. Youli Zhang · 1 shared paper, 2020 · strength 0.10
  9. Jingyu Min · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.